Cost-effectiveness analysis of humanitarian relief interventions: Visceral leishmaniasis treatment in the Sudan

Health Policy and Planning

Volumn 14, Issue 1, 1999, Pages 70-76

  Griekspoor, André ^a   Sondorp, Egbert ^b   Vos, Theo ^b  

^a MÉDECINS SANS FRONTIÈRES   (Switzerland)

^b Department of Human Services ^*

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DATA BASE; EPIDEMIC; HEALTH CARE FINANCING; HEALTH CARE MANAGEMENT; INTERNATIONAL COOPERATION; MORTALITY; PERFORMANCE; SUDAN; VISCERAL LEISHMANIASIS;

AFRICA; ARAB COUNTRIES; COST EFFECTIVENESS; DEVELOPING COUNTRIES; DISEASES; ECONOMIC FACTORS; EPIDEMICS; EVALUATION; EVALUATION INDEXES; FINANCIAL ACTIVITIES; FOREIGN AID; INTERNATIONAL COOPERATION; LEISHMANIASIS; NORTHERN AFRICA; ORGANIZATION AND ADMINISTRATION; PARASITIC DISEASES; PLANNING; QUANTITATIVE EVALUATION; RESEARCH REPORT; SUDAN; TREATMENT;

ALTRUISM; ANTIPROTOZOAL AGENTS; COST-BENEFIT ANALYSIS; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; DISABLED PERSONS; HEALTH SERVICES RESEARCH; HUMANS; LEISHMANIASIS, VISCERAL; OUTCOME ASSESSMENT (HEALTH CARE); PROGRAM EVALUATION; RELIEF WORK; SUDAN; VALUE OF LIFE;

EID: 0033024772     PISSN: 02681080     EISSN: None     Source Type: Journal    
DOI: 10.1093/heapol/14.1.70     Document Type: Article

References (21)

1. Bennet J, Kayetisi-Blewitt M. Beyond 'working in conflict': Understanding conflict and building peace. Relief and Rehabilitation Network, Network paper 18, November 1996.
2. World Bank. World Development Report 1993: Investing in health. New York: Oxford University Press, 1993.
3. Paalman M, Bekedam H, Hawken L et al. A critical review of priority setting in the health sector: the methodology of the 1993 World Development Report. Health Policy and Planning 1998; 13: 13-31.
4. Loevinsohn BP, Sutter RW, Costales MO. Using cost-effectiveness analysis to evaluate targeting strategies: the case of vitamin A supplementation. Health Policy and Planning 1997; 12: 29-37.
5. Politi C, Carrin G, Evans D et al. Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda. Health Economics 1995; 4: 273-87.
6. Daly CC, Franco L, Chilongozi DAT et al. A cost comparison of approaches to sexually transmitted disease treatment in Malawi. Health Policy and Planning 1998; 13: 87-93.
7. Floyd K, Wilkinson D, Gilks C. Comparison of cost-effectiveness of directly observed treatment (DOT) and conventionally delivered treatment for tuberculosis: experience from rural South Africa. British Medical Journal 1997; 315: 1407-41.
8. Ashworth A, Khanum S. Cost-effective treatment for severely malnourished children: what is the best approach? Health Policy and Planning 1997; 12: 115-21.
9. Naficy A, Rao MR, Paquet C et al. Treatment and vaccination strategies to control cholera in sub-Saharan refugee settings: a cost-effectiveness analysis. Journal of the American Medical Association 1998; 279: 521-5.
10. Hallam A. Cost Effectiveness Analysis: a useful tool for the assessment and evaluation of relief operations? Relief and Rehabilitation Network, Network paper 15, April 1996.
11. th edition. Saunders, 1996: 1231-4
12. Isselbacher KJ, Braunwald E, Wilson JD, Martin JB, Fauci AS, Kasper DL. Harrison's Principles of Internal Medicine. 13th edition. New York: McGraw-Hill, 1994: 897.
13. Seaman J, Ashford RW, Schorscher J, Dereure J. Visceral leishmaniasis in Southern Sudan: status of healthy villagers in epidemic conditions. Annals of Tropical Medicine and Parasitology 1992; 86(5): 481-6.
14. Meredith SEO, Kroon NCM, Sondorp HE et al. Leish-KIT: a stable direct agglutination test based on freeze dried antigen for the sero-diagnosis of Visceral Leishmaniasis. Journal of Clinical Microbiology 1995; 33: 1742-5.
15. Harith A, Kolk AHJ, Leeuwenberg J et al. Improvement of a Direct Agglutination Test for field studies of Visceral Leishmaniasis. Journal of Clinical Microbiology 1988; 26: 1321-5.
16. Seaman J, Mercer AJ, Sondorp HE. The epidemic of visceral leishmaniasis in Western Upper Nile, Southern Sudan: course and impact from 1984-1994. International Journal of Epidemiology 1996; 25: 862-71.
17. Seaman J, Mercer AJ, Sondorp HE, Herwaldt BL. Epidemic Visceral Leishmaniasis in Southern Sudan: treatment of severely debilitated patients under wartime conditions and with limited resources. Annals of Internal Medicine 1996; 124: 664-72.
18. Murray CJL. Rethinking DALYs. In: Murray CJL, Lopez AD. The global burden of disease. Harvard University Press, 1996.
19. Gold MR, Siegel JE, Russel LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press, 1996: 247-75.
20. Jamison DT, Mosley WH, Measham AR, Bobadilla JL. Disease control priorities in developing countries. New York: Oxford University Press, 1993: 15-30.
21. Barker C, Green A. Opening the debate on DALYs. Health Policy and Planning 1996; 11: 179-83.